Advertisement

Supplemental Material

The links to relevant recommendations of the American College of Obstetricians and Gynecologists are provided as the primary source of supplemental information to that provided in Clinical Updates in Women's Health Care monographs when applicable. The links to resources other than those of the American College of Obstetricians and Gynecologists are provided for information purposes only, and referral to these resources does not imply the endorsement of the American College of Obstetricians and Gynecologists.

Lower Urinary Tract Disorders (Vol VII, No 4)

For information on evaluation of uncomplicated stress urinary incontinence in women before surgical treatment refer to: Evaluation of Uncomplicated Stress Urinary Incontinence in Women Before Surgical Treatment. Committee Opinion No. 603. American College of Obstetricians and Gynecologists and American Urogynecologic Society.

For information on onabotulinumtoxinA and the bladder refer to: OnabotulinumtoxinA and the Bladder. Committee Opinion No. 604. American College of Obstetricians and Gynecologists and American Urogynecologic Society.

For the latest patient information regarding overactive bladder symptoms refer to http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm426099.htm

For clinical practice guidelines on urinary incontinence refer to Urinary incontinence in women. Practice Bulletin No. 155. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e66-81.

 




Editor
Russell R. Snyder, MD

Associate Editor
Gretchen M. Lentz, MD

Past Editor
Raul Artal, MD

ISSN 1536-3619
Published 6 times per year